Proteomics

Dataset Information

0

Timed topical dexamethasone eye drops improve mitochondrial function to suppress severe retinopathy of prematurity.


ABSTRACT: Pathological neovascularization (NV) can cause visual impairment in retinopathy of prematurity (ROP). Current treatments addressing vasoproliferative (Phase II) ROP are costly and can lead to severe complications. We show that well-timed topical 0.1% dexamethasone eye drops during early retinal neovascular formation prevents NV in five extremely preterm infants at high risk for ROP and in mouse oxygen-induced retinopathy (OIR) modeling ROP. In OIR mice, daily treatment before any NV has limited efficacy in mitigating NV, while treatment after peak NV exhibits no statistically significant effect but with a trend to exacerbating NV. Optimally timed topical dexamethasone suppression of NV in OIR is associated with increased retinal mitochondrial gene expression and a decrease in inflammatory markers predominantly expressed in immune cells. This study provides new insights into topical steroid effects in retinal NV and into mitochondrial function in phase II ROP, and suggests a simple approach to preventing severe ROP.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Retina

SUBMITTER: Zhongjie Fu  

LAB HEAD: Zhongjie fu

PROVIDER: PXD052730 | Pride | 2025-05-07

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
41_HY_P17H.mzML Mzml
41_HY_P17H.mzid.gz Mzid
41_HY_P17H.pdResult Other
41_HY_P17H.zip Other
41_HY_P17H_Dexa_1.raw Raw
Items per page:
1 - 5 of 17
altmetric image

Publications


Pathological neovascularization in retinopathy of prematurity (ROP) can cause visual impairment in preterm infants. Current ROP treatments which are not preventative and only address late neovascular ROP, are costly and can lead to severe complications. We showed that topical 0.1% dexamethasone eye drops administered prior to peak neovessel formation prevented neovascularization in five extremely preterm infants at high risk for ROP and suppressed neovascularization by 30% in mouse oxygen-induce  ...[more]

Similar Datasets

2025-05-07 | PXD056490 | Pride
2025-05-07 | PXD059520 | Pride
2024-09-04 | GSE272252 | GEO
2021-11-04 | PXD027902 | Pride
2022-04-20 | GSE198785 | GEO
2022-12-29 | GSE221861 | GEO
2022-12-29 | GSE221860 | GEO
2019-12-31 | GSE135844 | GEO
2025-04-22 | PXD056245 | Pride
2011-10-13 | E-GEOD-32948 | biostudies-arrayexpress